CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 602 shares at $187.95 ($113,146)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 4,570 shares at an average $176.60 ($807,042)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $159.99 ($479,969)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 1,364 shares at $162.05 ($221,040)
- 4 Planned sale CEO AND PRESIDENT sold 23,192 shares at an average $160.80 ($3,729,372)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 2,491 shares at $162.05 ($403,674)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 14,070 shares at an average $178.70 ($2,514,354)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 50,000 shares at an average $180.33 ($9,016,668)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Gift PRESIDENT, CLINICALDIAGNOSTICS gave 300 shares (gift)
- 144 Insider Sale of Securities
- 4 Planned sale EXECUTIVE CHAIRMAN sold 5,000 shares at an average $170.54 ($852,707)
Page 18 of 94 · 1,862 filings